Companies / Journey Medical Corp

Journey Medical Corp

Nasdaq: DERMCIK 1867066SCOTTSDALE, AZ

Financials · FY2025

Revenue$61.86M
Net income$-11.43M
Total debt$25.47M
Cash$25.64M
Diluted EPS$-0.47
Shares outstanding28.2M

Ownership

28.2M shares outstanding · as of Aug 11, 2026
0.42%Insiders
Ownership
78.7%Class M
Share classes
Class M78.74%
Class A21.26%
Insiders0.42%118,618
Institutions35.67%10,067,411
Public float63.91%18,038,366

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 1

View all →
Insider% of sharesShares
0.42%118,618

Institutional holders 80

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
TrimCommon Stock$-4.38M-619K
-85.97%
100,981
0.36% of shares
low
Q1 2026
as of
Tang Capital Management, LLC
13F manager
TrimCommon Stock$-1.15M-245K
-13.19%
1,610,000
5.70% of shares
low
Q2 2026
as of
State Street Corporation
13F manager
TrimCommon Stock$-760.1K-107K
-61.94%
65,978
0.23% of shares
low
Q1 2026
as of
Geode Capital Management, LLC
13F manager
AddCommon Stock$700.1K+149K
+47.53%
463,202
1.64% of shares
low
Q1 2026
as of
AQR Capital Management, LLC
13F manager
ExitCommon Stock$-395.3K-51K
-100.00%
low
Q1 2026
as of
Millennium Management LLC
13F manager
TrimCommon Stock$-350.6K-75K
-16.33%
383,067
1.36% of shares
low
Q2 2026
as of
Quadrature Capital Ltd
13F manager
NewCommon Stock$204.2K+29K
28,841
0.10% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
NewCommon Stock$160.9K+22K
22,403
0.08% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
DERMCommon StockEquity48115J109BBG00ZWVDRK2